FDA Investigator Eric L Vangraafeiland
Eric L Vangraafeiland has conducted inspections on 43 sites in 3 countries as of 04 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
43
Last Inspection Date:
04 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America,
Italy,
Spain
FDA Investigators that have inspected at least one site in common with Eric L Vangraafeiland:
Adriana N Jimenez Lopez,
Amanda M Osteen,
Amos C Epps,
Andrea L Williams Jones,
Andrew J Howard,
Andrew M Kolenc,
Anthony M Criscuolo, Jr,
Billingsley,
Brandon J Brookens,
Brandon M Kurjanowicz,
Brent W Higgs,
Brian R Yaun,
Bruce C Kovak,
Calvin W Edwards,
Carla R Hinz,
Cary Greene,
Charlean R Butler,
Charles E Idjagboro,
Christine L Williams,
Christopher L Taste,
Christopher R Richardson,
Clarice J Ahn,
Conrad M Guardia,
Daniel Pst Laurent,
Daniel W Johnson,
David P Rice, Jr,
Deborah H Cozzone,
Debra L Curtis,
Dennis L Doupnik,
Deshonna L Mitchell,
Edward P Potter,
Edwin J Gorney,
Elisa J Beard,
Eric S Myskowski,
Erik T Nagaoka,
Esaw,
Gale L Glinecki,
Gerald W Kopp,
Gretchen N Kilby,
Heath A Gerber,
Holly L Miller,
Isabel Y Espinosa,
Jacqueline Johnson,
James M Odonnell,
James P Mcevoy,
Jamie D Richardson,
Jamie D Swann,
Jason P Aun,
Jeffrey A Reed,
Jennifer A Baker,
Jennifer A Robinson,
Jennifer R Mathern,
Jesse P Hardin,
Jessica B Darneille,
Jessica D Nanini,
Jessica K Yoon,
John Dan,
Joseph L Despins, PhD,
Julie M Anbarchian,
Justin A Hefferman,
Karen A Spencer,
Latoya S Oliver Powell,
Lavender M Huskey,
LCDR Cornelius Brown, III,
LCDR Wilfred A Darang,
Marc A Jackson, Jr,
Mary F Bodick,
Matthew A Johnson,
Matthew R Dionne,
Maureen A Wentzel,
Merideth K Rose,
Michael D Ellison,
Michael F Mccoy,
Mildred L Mccray,
Mohamad A Chahine,
Natasha A Dezinna,
Nebil A Oumer,
Nicole J Clausen,
Norman Fogg,
Rafael H Ortiz,
Regina Gibson Melton,
Sarah J Park,
Sierra M Shockley,
Tamara N Champion,
Tammy M Phillips,
Theressa B Smith,
Trevor R Beach,
Valeria A Moore,
William D Murray
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more